ATE359766T1 - Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten - Google Patents

Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten

Info

Publication number
ATE359766T1
ATE359766T1 AT03706749T AT03706749T ATE359766T1 AT E359766 T1 ATE359766 T1 AT E359766T1 AT 03706749 T AT03706749 T AT 03706749T AT 03706749 T AT03706749 T AT 03706749T AT E359766 T1 ATE359766 T1 AT E359766T1
Authority
AT
Austria
Prior art keywords
tablet core
coating
pharmaceutical dosage
core
qcm
Prior art date
Application number
AT03706749T
Other languages
English (en)
Inventor
Wei Tian
John Langridge
Marshall Whiteman
Original Assignee
Phoqus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoqus Pharmaceuticals Ltd filed Critical Phoqus Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE359766T1 publication Critical patent/ATE359766T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03706749T 2002-02-28 2003-02-28 Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten ATE359766T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0204772.8A GB0204772D0 (en) 2002-02-28 2002-02-28 Pharmaceutical dosage forms

Publications (1)

Publication Number Publication Date
ATE359766T1 true ATE359766T1 (de) 2007-05-15

Family

ID=9932020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706749T ATE359766T1 (de) 2002-02-28 2003-02-28 Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten

Country Status (12)

Country Link
US (1) US20050142199A1 (de)
EP (1) EP1478350B1 (de)
JP (1) JP2005524654A (de)
AT (1) ATE359766T1 (de)
AU (1) AU2003208461A1 (de)
CA (1) CA2476171A1 (de)
DE (1) DE60313296T2 (de)
ES (1) ES2282604T3 (de)
GB (1) GB0204772D0 (de)
PT (1) PT1478350E (de)
WO (1) WO2003072086A1 (de)
ZA (1) ZA200406194B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6776792B1 (en) 1997-04-24 2004-08-17 Advanced Cardiovascular Systems Inc. Coated endovascular stent
US6783793B1 (en) 2000-10-26 2004-08-31 Advanced Cardiovascular Systems, Inc. Selective coating of medical devices
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
CA2549195A1 (en) * 2003-12-09 2005-06-23 Spherics, Inc. Bioadhesive polymers with catechol functionality
US7563324B1 (en) 2003-12-29 2009-07-21 Advanced Cardiovascular Systems Inc. System and method for coating an implantable medical device
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US7390524B1 (en) 2004-05-20 2008-06-24 Advanced Cardiovascular Systems, Inc. Method for electrostatic spraying of an abluminal stent surface
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
US7632307B2 (en) 2004-12-16 2009-12-15 Advanced Cardiovascular Systems, Inc. Abluminal, multilayer coating constructs for drug-delivery stents
MX2007007836A (es) * 2004-12-27 2007-08-20 Eisai R&D Man Co Ltd Metodo para estabilizar un farmaco anti-demencia.
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
PT1976522E (pt) 2005-12-30 2013-09-09 Krka Tovarna Zdravil D D Novo Mesto Composição farmacêutica contendo montelucaste
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
BRPI0907423A2 (pt) * 2008-01-11 2020-10-27 Reata Pharmaceuticals, Inc. composto triterpenoide sintético para uso em um método de melhoria da função renal em um indivíduo, e uso do referido composto
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
TWI455733B (zh) * 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
WO2011025881A1 (en) * 2009-08-28 2011-03-03 Hercules Incorporated Film coating composition from solid powder compounds
US8663671B2 (en) 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
CN102008393B (zh) * 2010-11-12 2012-11-28 罗彦凤 干法包衣设备
ES2975449T3 (es) 2017-05-22 2024-07-05 Johnson & Johnson Consumer Inc Forma farmacéutica de pastilla

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2253164B (en) * 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
US6277409B1 (en) * 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
GB0117619D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form

Also Published As

Publication number Publication date
DE60313296D1 (de) 2007-05-31
JP2005524654A (ja) 2005-08-18
PT1478350E (pt) 2007-07-13
GB0204772D0 (en) 2002-04-17
ZA200406194B (en) 2006-06-28
EP1478350A1 (de) 2004-11-24
WO2003072086A1 (en) 2003-09-04
US20050142199A1 (en) 2005-06-30
DE60313296T2 (de) 2007-12-27
AU2003208461A1 (en) 2003-09-09
ES2282604T3 (es) 2007-10-16
CA2476171A1 (en) 2003-09-04
EP1478350B1 (de) 2007-04-18

Similar Documents

Publication Publication Date Title
ATE359766T1 (de) Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten
DK1246622T3 (da) Nye substituerede benzimidazol dosisformer og metoder til deres anvendelse
JP2005524658A5 (de)
MX2021014339A (es) Preparacion de granulo inhibidor de parp y proceso de preparacion del mismo.
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
SI1476138T1 (sl) Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola
MX2009000730A (es) Liberacion controlada de formulaciones y metodos asociados.
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
MY136406A (en) High drug load tablet
CA2457361A1 (en) Opioid agonist formulations with releasable and sequestered antagonist
MXPA04007427A (es) Formulaciones de azitromicina granuladas por via seca.
ATE321537T1 (de) Pharmazeutische zubereitung enthaltend doxazosin
CA2477260A1 (en) Site specific delivery of co-administered drugs via inhalation
MX2007006212A (es) Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular.
SI1578406T1 (sl) Farmacevtska oblika s prirejenim sproščanjem
JP2010540547A5 (de)
MX2009000849A (es) Formas de dosificacion liofilizadasdisolvibles oralmente/desintegrables que contienen particulas protegidas.
MY127350A (en) Flash-melt oral dose formulations
WO2005007137A3 (de) Ambroxolhaltige tabletten
MX2010007281A (es) Composiciones farmaceuticas de amlodipina y valsartan.
WO2021016012A8 (en) Pretomanid compositions
DE60018629D1 (de) Carbamazepinformulierung mit verzögerter Freigabe
WO2008079343A3 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1478350

Country of ref document: EP

REN Ceased due to non-payment of the annual fee